Vimarsana
Biggest News Aggregation in the World

Page 3 - Vida Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Ventures Today - Breaking & Trending Today

Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated KIF18A Inhibitors - Vimarsana News

Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated KIF18A Inhibitors

NEW YORK--(BUSINESS WIRE)--Oct 30, 2023--

Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials - Vimarsana News

Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials

Avalyn Pharma aims to improve treatment of Idiopathic pulmonary fibrosis with inhalable versions of two older oral drugs and it’s now headed for mid-stage testing backed by a Series C financing. Other recent biotech industry financings raised money for research in cancer, immunology, and rare genetic diseases.

Avalyn Pharma Closes $175M Series C Financing - Vimarsana News

Avalyn Pharma Closes $175M Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

ReCode Therapeutics Raises Additional USD50M in Series B Financing - Vimarsana News

ReCode Therapeutics Raises Additional USD50M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Radiopharmaceuticals for cancer: Making radiation precise - Vimarsana News

Radiopharmaceuticals for cancer: Making radiation precise

BioPharma